Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
Somatic loss of function mutations in cohesin genes are frequently associated with various cancer types, while cohesin disruption in the germline causes cohesinopathies such as Cornelia-de-Lange syndrome (CdLS). Here, we present the discovery of a recurrent heterozygous RAD21 germline aberration at amino acid position 298 (p.P298S/A) identified in three children with lymphoblastic leukemia or lymphoma in a total dataset of 482 pediatric cancer patients. While RAD21 p.P298S/A did not disrupt the formation of the cohesin complex, it altered RAD21 gene expression, DNA damage response and primary patient fibroblasts showed increased G2/M arrest after irradiation and Mitomycin-C treatment. Subsequent single-cell RNA-sequencing analysis of healthy human bone marrow confirmed the upregulation of distinct cohesin gene patterns during hematopoiesis, highlighting the importance of RAD21 expression within proliferating B- and T-cells. Our clinical and functional data therefore suggest that RAD21 germline variants can predispose to childhood lymphoblastic leukemia or lymphoma without displaying a CdLS phenotype.
Details
Original language | English |
---|---|
Article number | 5174 |
Journal | International journal of molecular sciences |
Volume | 23 |
Issue number | 9 |
Publication status | Published - 1 May 2022 |
Peer-reviewed | Yes |
External IDs
PubMedCentral | PMC9106003 |
---|---|
Scopus | 85129433052 |
Keywords
Sustainable Development Goals
Keywords
- Apoptosis, Cell Cycle Proteins/genetics, Cell Line, Tumor, Child, DNA-Binding Proteins/genetics, De Lange Syndrome/genetics, G2 Phase Cell Cycle Checkpoints, Germ Cells/metabolism, Humans, Lymphoma/genetics, Mutation, Phenotype, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics